Identifying a gene expression signature of frequent COPD exacerbations in peripheral blood using network methods

BMC Medical Genomics

Volumn 8, Issue 1, 2015, Pages

  Morrow, Jarrett D ^a   Qiu, Weiliang ^a   Chhabra, Divya ^a,b   Rennard, Stephen I ^c   Belloni, Paula ^d   Belousov, Anton ^e   Pillai, Sreekumar G ^f,g   Hersh, Craig P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d GENENTECH INC   (United States)

^e ROCHE DIAGNOSTICS GMBH   (Germany)

^f HOFFMANN LA ROCHE INC   (United States)

^g ELI LILLY AND COMPANY   (United States)

Author keywords

Biomarker; Chronic obstructive pulmonary disease; Gene expression profiling; Network analysis

Indexed keywords

BIOLOGICAL MARKER; CELL MARKER; MYELOPEROXIDASE; TRANSCRIPTOME;

AGED; ARTICLE; B LYMPHOCYTE; BLOOD ANALYSIS; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS INFECTION; ALGORITHM; BIOLOGY; BLOOD; CROSS-SECTIONAL STUDY; EMPHYSEMA; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SEQUENCE ANALYSIS; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

BACTERIA (MICROORGANISMS);

AGED; ALGORITHMS; BIOMARKERS; COMPUTATIONAL BIOLOGY; CROSS-SECTIONAL STUDIES; EMPHYSEMA; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEQUENCE ANALYSIS, RNA; SEVERITY OF ILLNESS INDEX; TRANSCRIPTOME;

EID: 84928008785     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/s12920-014-0072-y     Document Type: Article

References (34)

1. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347-65.
2. Alfredo P, Gaetano C, Paolo C, Marco C, Johnston SL, Alberto P. Pathophysiology of viral-induced exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2007;2:477-83.
3. Foreman MG, DeMeo DL, Hersh CP, Reilly JJ, Silverman EK. Clinical determinants of exacerbations in severe, early-onset COPD. Eur Respir J. 2007;30:1124-30.
4. Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128-38.
5. Foreman MG, DeMeo DL, Hersh CP, Carey VJ, Fan VS, Reilly JJ, et al. Polymorphic variation in surfactant protein B is associated with COPD exacerbations. Eur Respir J. 2008;32:938-44.
6. Takabatake N, Shibata Y, Abe S, Wada T, Machiya J, Igarashi A, et al. A single nucleotide polymorphism in the CCL1 gene predicts acute exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;174:875-85.
7. Hansel NN, Hilmer SC, Georas SN, Cope LM, Guo J, Irizarry RA, et al. Oligonucleotide-microarray analysis of peripheral-blood lymphocytes in severe asthma. J Lab Clin Med. 2005;145:263-74.
8. Herazo-Maya JD, Noth I, Duncan SR, Kim S, Ma S-F, Tseng GC, et al. Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis. Sci Transl Med. 2013;5:205ra136.
9. Yang IV, Luna LG, Cotter J, Talbert J, Leach SM, Kidd R, et al. The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis. PLoS One. 2012;7:e37708.
10. Poliska S, Csanky E, Szanto A, Szatmari I, Mesko B, Szeles L, et al. Chronic obstructive pulmonary disease-specific gene expression signatures of alveolar macrophages as well as peripheral blood monocytes overlap and correlate with lung function. Respiration. 2011;81:499-510.
11. Bhattacharya S, Tyagi S, Srisuma S, Demeo DL, Shapiro SD, Bueno R, et al. Peripheral blood gene expression profiles in COPD subjects. J Clin Bioinforma. 2011;1:12.
12. Bahr TM, Hughes GJ, Armstrong M, Reisdorph R, Coldren CD, Edwards MG, et al. Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2013;49:316-23.
13. Silverman E, Loscalzo J. Network medicine approaches to the genetics of complex diseases. Discov Med. 2012;14:143-52.
14. Haas BE, Horvath S, Pietiläinen KH, Cantor RM, Nikkola E, Weissglas-Volkov D, et al. Adipose co-expression networks across Finns and Mexicans identify novel triglyceride-associated genes. BMC Med Genomics. 2012;5:61.
15. Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity. 2014;40:274-88.
16. Jones P, Rames A. TESRA (Treatment of Emphysema with a Selective Retinoid Agonist) study results. Am J Respir Crit Care Med. 2011;A6418.
17. Cheng DT, Kim DK, Cockayne DA, Belousov A, Bitter H, Cho MH, et al. Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188:948-57.
18. Gautier L, Cope L, Bolstad BM, Irizarry RA. Affy-analysis of affymetrix GeneChip data at the probe level. Bioinforma Oxf Engl. 2004;20:307-15.
19. Smyth GK. Limma: Linear Models for Microarray Data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, editors. Bioinforma Comput Biol Solut Using R Bioconductor. New York: Springer; 2005. p. 397-420.
20. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995;57:289-300.
21. Horvath S. Weighted Network Analysis: Applications in Genomics and Systems Biology. 2011th ed. New York: Springer; 2011.
22. Feng G, Du P, Krett NL, Tessel M, Rosen S, Kibbe WA, et al. A collection of bioconductor methods to visualize gene-list annotations. BMC Res Notes. 2010;3:10.
23. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL. Gene set enrichment analysis: a knowledge-based approach for interpreting genomewide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545-50.
24. Merico D, Isserlin R, Stueker O, Emili A, Bader GD. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One. 2010;5:e13984.
25. Hodge G, Mukaro V, Holmes M, Reynolds PN, Hodge S. Enhanced cytotoxic function of natural killer and natural killer T-like cells associated with decreased CD94 (Kp43) in the chronic obstructive pulmonary disease airway. Respirology. 2013;18:369-76.
26. Veljkovic E, Jiricny J, Menigatti M, Rehrauer H, Han W. Chronic exposure to cigarette smoke condensate in vitro induces epithelial to mesenchymal transition-like changes in human bronchial epithelial cells, BEAS-2B. Toxicol In Vitro. 2011;25:446-53.
27. Doyle I, Ratcliffe M, Walding A, Vanden Bon E, Dymond M, Tomlinson W, et al. Differential gene expression analysis in human monocyte-derived macrophages: impact of cigarette smoke on host defence. Mol Immunol. 2010;47:1058-65.
28. Bosco A, Ehteshami S, Stern DA, Martinez FD. Decreased activation of inflammatory networks during acute asthma exacerbations is associated with chronic airflow obstruction. Mucosal Immunol. 2010;3:399-409.
29. Ioannidis I, McNally B, Willette M, Peeples ME, Chaussabel D, Durbin JE, et al. Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection. J Virol. 2012;86:5422-36.
30. Fiorini G, Crespi S, Rinaldi M. Serum ECP and MPO are increased during exacerbations of chronic bronchitis with airway obstruction. Biomed Pharmacother. 2000;54:274-8.
31. Gompertz S, Bayley DL, Hill SL, Stockley RA. Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax. 2001;56:36-41.
32. Tumkaya M, Atis S, Ozge C, Delialioglu N, Polat G, Kanik A. Relationship between airway colonization, inflammation and exacerbation frequency in COPD. Respir Med. 2007;101:729-37.
33. Gompertz S, O'Brien C, Bayley DL, Hill SL, Stockley RA. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J. 2001;17:1112-9.
34. Cockayne DA, Cheng DT, Waschki B, Sridhar S, Ravindran P, Hilton H, et al. Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity. PLoS One. 2012;7:e38629.